早期乳腺癌保乳术后IMRT与3D-CRT随机对照试验:KROG 15-03
韩国KROG 15-03随机试验纳入693例pT1-2N0M0早期乳腺癌保乳术后患者,比较IMRT与3D-CRT。两组3年局部区域无复发生存无显著差异,IMRT靶区适形指数更优、同侧肺剂量更低、≥2级皮炎发生率更低。
要点
- IMRT与3D-CRT的3年局部区域无复发生存无显著差异。
- IMRT靶区适形指数显著优于3D-CRT(p<0.001)。
- IMRT同侧肺平均剂量及V5-V50显著更低,≥2级皮炎更少。
核心结论
- 与3D-CRT相比,IMRT局部区域肿瘤控制相似,但靶区覆盖更优。
- 乳腺癌IMRT可降低同侧肺照射剂量和皮肤毒性。
研究设计与样本
- 前瞻性随机对照试验,2015年3月至2018年2月入组693例pT1-2N0M0早期乳腺癌保乳术后患者。
- 随机分为IMRT组344例和3D-CRT组349例,主要终点为3年局部区域无复发生存。
主要发现
- 两组局部区域无复发生存无显著差异。
- IMRT组靶区适形指数显著优于3D-CRT组(p<0.001)。
- IMRT组同侧肺平均剂量及V5-V50均显著低于3D-CRT组(均p<0.05)。
- IMRT组≥2级皮炎发生率显著低于3D-CRT组(p=0.009)。
关键数值与推荐
- 3D-CRT方案:59.4 Gy/33次,6.5周。
- IMRT方案:57.4 Gy/28次,同步整合推量,5.5周。
临床怎么用
- 早期乳腺癌保乳术后可选用IMRT以改善靶区覆盖并降低同侧肺剂量和皮肤毒性。
- IMRT与3D-CRT的局部区域控制效果相似。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the safety and efficacy of intensity-modulated radiation therapy (IMRT) for early breast cancer compared with 3-dimensional conformal radiotherapy (3D-CRT) in a prospective and randomized trial. METHODS AND MATERIALS: From March 2015 to February 2018, 693 patients with pT1-2N0M0 early breast cancer who underwent breast-conserving surgery were enrolled and randomly assigned into IMRT and 3D-CRT. The primary endpoint was 3-year locoregional recurrence-free survival (LRRFS). The secondary endpoints were recurrence-free survival, overall survival, acute toxicity, target coverage index, irradiation dose to organs at risk, and fatigue inventory. The radiation dose for the 3D-CRT arm was 59.4 Gy in 33 fractions for 6.5 weeks. It was 57.4 Gy in 28 fractions with simultaneous integrated boost for 5.5 weeks for the IMRT arm. RESULTS: Of 693 patients, 349 and 344 patients received 3D-CRT and IMRT, respectively. There was no significant difference in LRRFS between the two arms. Conformity index of planning target volume was significantly superior in the IMRT arm than the 3D-CRT arm (p < 0.001). The mean lung dose and V5-V50 for the ipsilateral lung were significantly lower in the IMRT arm than the 3D-CRT arm (all p < 0.05). The incidence of grade 2 or higher dermatitis was significantly lower in the IMRT arm (p = 0.009). CONCLUSION: Compared to 3D-CRT, IMRT showed similar results in locoregional tumor control but superior results in planning target volume coverage. When IMRT is used in breast cancer, the irradiation dose to an ipsilateral lung and skin toxicity can be reduced.
引用
- Choi KH, Ahn SJ, Jeong JU, et al. Postoperative radiotherapy with intensity-modulated radiation therapy versus 3-dimensional conformal radiotherapy in early breast cancer: A randomized clinical trial of KROG 15-03. Radiother Oncol. 2020. PMID: 32980384. doi:10.1016/j.radonc.2020.09.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。